ClinicalMetric / Countries / Israel / ovarian cancer recurrent
← 🇮🇱 Israel Trials
🇮🇱 Israel Country × Condition

ovarian cancer recurrent Clinical Trials in Israel

Active clinical trials for ovarian cancer recurrent with research sites in Israel. All data sourced live from ClinicalTrials.gov — updated daily.

Active Trials: 1 // Recruiting: 1 Phases: Phase 1, Phase 2 // Updated: Daily
Total Trials
1
Recruiting Now
1
Country
🇮🇱 Israel

Active Trials in Israel (1)

NCT06843447 Phase 1, Phase 2
Recruiting

A Clinical Study of Raludotatug Deruxtecan in People With Ovarian Cancer (MK-5909-003)

Enrollment
460 pts
Country
🇮🇱 Israel
Merck Sharp & Dohme LLC
View Trial →

Frequently Asked Questions

How many ovarian cancer recurrent clinical trials are active in Israel?
There are currently 1 active clinical trials for ovarian cancer recurrent with sites in Israel, of which 1 are actively recruiting patients.
How can I join a ovarian cancer recurrent clinical trial in Israel?
To join a ovarian cancer recurrent clinical trial in Israel, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Israel directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are ovarian cancer recurrent trials in Israel?
Active ovarian cancer recurrent trials in Israel span Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
Browse More
All Israel Trials → Global ovarian cancer recurrent Trials → All Countries → All Trials →
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology